Electronic Aspirin: Future of Migraine Treatment
Technological advancements have made our lives more easy and comfortable. A migraine or paralysing headaches have become common in most parts in the world. Often related to stress, genetics and lifestyle these headaches are known to impair normal functions for patients.
To make the lives of Migraine patients more comfortable & peaceful, Autonomic Technologies Inc. (ATI) in Redwood City, California is making honest endeavours. They are evaluating the impressive device viz., Electronic Aspirin. ATI, who is also the maker of ATI Neurostimulation System, showed that the device is capable of effectively treating the cluster headaches and improving the overall quality of life. The study included 22 patients, of which 70% benefited with the device reporting a 50% reduction in pain over a period of four weeks. The ATI Neurostimulation System was approved by the U.S. FDA for testing in domestic waters in August 2014. Currently, the device remains under intensive study and is expected to be thoroughly investigated over a period of several years before it can be offered to the patients commercially.
The demand for electronic aspirin is always high in the regions which are densely populated. Hence, Asia-Pacific region and especially India is one of the most prime & potential markets for electronic aspirin industry. The only barrier for the industry in emerging countries like India is the slow up gradation and advancement of technology. Fast improving technology is one of the major driving factors which help this industry spreading its wings in developed countries.
Still, with a high population of 1,252.14 million (and still counting) India remains one of the biggest economies in the world. Even though the country has faced several economic issues consistently, it has good per capita income. Being unified in the diverse demographics, the country possesses favourable conditions for the wide spread of electronic aspirin industry. Hence, in the forecast period, electronic aspirin market is projected to grow with double digit CAGR (compound annual growth rate). This is an optimistic scenario indeed.
Related ReportsGlobal Drugs for Sinusitis Market Research Report 2011-2023 Global EEG Equipment Market Report for Period 2011 to 2023 Market Share, Size, Analysis, Historical Data, Forecast and Manufacturer Profiles Global Depression Drugs Market Report for Period 2011 to 2023 Market Share, Size, Analysis, Historical Data, Forecast and Manufacturer Profiles
▼ Market Research Reports ▼
- Agriculture (111)
- Automotive (432)
- Chemicals and Materials (4157)
- Consumer Goods (818)
- Defense and Aeronautics (87)
- Electronics (1328)
- Energy and Mining (122)
- Equipment (1881)
- Food and Beverages (433)
- Healthcare (596)
- Manufacturing and Construction (274)
- Market Research (40)
- Medical Devices (547)
- Packaging (5)
- Pharmaceutical (212)
- Technology and Media (132)